Search Results - "BERRINO, Liberato"

Refine Results
  1. 1

    Current pharmacological treatments for COVID‐19: What's next? by Scavone, Cristina, Brusco, Simona, Bertini, Michele, Sportiello, Liberata, Rafaniello, Concetta, Zoccoli, Alice, Berrino, Liberato, Racagni, Giorgio, Rossi, Francesco, Capuano, Annalisa

    Published in British journal of pharmacology (01-11-2020)
    “…Since December 2019 SARS‐Cov‐2 was found responsible for the disease COVID‐19, which has spread worldwide. No specific therapies/vaccines are yet available for…”
    Get full text
    Journal Article
  2. 2

    Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib by Rosano, Giuseppe, Malara, Natalia, Berrino, L., De Angelis, A., Gorini, Stefania, Ferraro, Elisabetta

    Published in Oxidative medicine and cellular longevity (01-01-2018)
    “…Many cancer therapies produce toxic side effects whose molecular mechanisms await full elucidation. The most feared and studied side effect of chemotherapeutic…”
    Get full text
    Journal Article
  3. 3

    Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity by Urbanek, Konrad, Naviglio, Silvio, Rossi, Francesco, Quaini, F., Illiano, Michela, Prezioso, Lucia, Sapio, Luigi, De Angelis, A., Cappetta, Donato, Berrino, L.

    Published in Oxidative medicine and cellular longevity (01-01-2017)
    “…The production of reactive species is a core of the redox cycling profile of anthracyclines. However, these molecular characteristics can be viewed as a…”
    Get full text
    Journal Article
  4. 4
  5. 5

    SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy by Cappetta, Donato, Esposito, Grazia, Piegari, Elena, Russo, Rosa, Ciuffreda, Loreta Pia, Rivellino, Alessia, Berrino, Liberato, Rossi, Francesco, De Angelis, Antonella, Urbanek, Konrad

    Published in International journal of cardiology (15-02-2016)
    “…Abstract Background Doxorubicin (DOXO) is an effective anti-neoplastic drug but its clinical benefits are hampered by cardiotoxicity. Oxidative stress,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity by Piegari, Elena, Cozzolino, Anna, Ciuffreda, Loreta Pia, Cappetta, Donato, De Angelis, Antonella, Urbanek, Konrad, Rossi, Francesco, Berrino, Liberato

    Published in Scientific reports (23-07-2020)
    “…Cardiotoxicity remains a serious problem in anthracycline-treated oncologic patients. Therapeutic modulation of microRNA expression is emerging as a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? by Mascolo, Annamaria, Urbanek, Konrad, De Angelis, Antonella, Sessa, Maurizio, Scavone, Cristina, Berrino, Liberato, Rosano, Giuseppe Massimo Claudio, Capuano, Annalisa, Rossi, Francesco

    Published in Heart failure reviews (01-03-2020)
    “…Atrial fibrillation (AF) is a significant cause of morbidity and mortality as well as a public health burden considering the high costs of AF-related…”
    Get full text
    Journal Article
  10. 10

    Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury by Cione, Erika, Siniscalchi, Antonio, Gangemi, Pietro, Cosco, Lucio, Colosimo, Manuela, Longhini, Federico, Luciani, Filippo, De Sarro, Giovambattista, Berrino, Liberato, D'Agostino, Bruno, Gallelli, Luca

    Published in PloS one (19-05-2021)
    “…The multifunctional role of neuron-specific enolase (NSE) in lung diseases is well established. As the lungs are greatly affected in COVID-19, we evaluated…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System by Scavone, Cristina, Mascolo, Annamaria, Ruggiero, Rosanna, Sportiello, Liberata, Rafaniello, Concetta, Berrino, Liberato, Capuano, Annalisa

    Published in Frontiers in pharmacology (15-04-2020)
    “…The use of quinolones has been associated with the development of serious and persistent adverse drug reaction (ADR) mainly affecting muscles, joints and the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs by Scavone, Cristina, di Mauro, Gabriella, Mascolo, Annamaria, Berrino, Liberato, Rossi, Francesco, Capuano, Annalisa

    Published in Frontiers in pharmacology (13-02-2019)
    “…Despite several innovative medicines gaining worldwide approval in recent years, there are still therapeutic areas for which unsatisfied therapeutic needs…”
    Get full text
    Journal Article
  15. 15

    The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 by Mascolo, Annamaria, Scavone, Cristina, Rafaniello, Concetta, De Angelis, Antonella, Urbanek, Konrad, di Mauro, Gabriella, Cappetta, Donato, Berrino, Liberato, Rossi, Francesco, Capuano, Annalisa

    Published in Frontiers in pharmacology (20-04-2021)
    “…The renin-angiotensin-aldosterone system (RAAS) firstly considered as a cardiovascular circulating hormonal system, it is now accepted as a local tissue system…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review by Mascolo, Annamaria, Scavone, Cristina, Rafaniello, Concetta, Ferrajolo, Carmen, Racagni, Giorgio, Berrino, Liberato, Paolisso, Giuseppe, Rossi, Francesco, Capuano, Annalisa

    Published in Frontiers in cardiovascular medicine (11-08-2020)
    “…Although clinical manifestations of the 2019 novel coronavirus disease pandemic (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2…”
    Get full text
    Journal Article
  19. 19
  20. 20